I. Introduction II. Disease Pathogenesis III. Disease Prediction A. Genetic prediction B. Immunological prediction C. Metabolic prediction IV. Prevention of Type I Diabetes A. Trial design B. Genetic prevention C. Prevention: preautoimmunity D. Prevention: postautoimmunity/prediabetes E. New onset patients/prevention of further β-cell destruction F. Pancreas and islet cell transplantation/prevention of recurrent diabetes G. Islet cell transplantation/prevention of β-cell destruction V. Conclusion
No takes yet. Share an insight, caveat, or question.
Slover et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: